LifeMD PE Ratio 2011-2025 | LFMD

Current and historical p/e ratio for LifeMD (LFMD) from 2011 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. LifeMD PE ratio as of May 23, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

LifeMD PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-23 11.53 0.00
2025-03-31 5.44 $-0.34 0.00
2024-12-31 4.95 $-0.54 0.00
2024-09-30 5.24 $-0.64 0.00
2024-06-30 6.86 $-0.70 0.00
2024-03-31 10.28 $-0.74 0.00
2023-12-31 8.29 $-0.70 0.00
2023-09-30 6.25 $-0.98 0.00
2023-06-30 4.35 $-1.04 0.00
2023-03-31 1.70 $-1.26 0.00
2022-12-31 1.94 $-1.57 0.00
2022-09-30 1.97 $-1.79 0.00
2022-06-30 2.04 $-2.07 0.00
2022-03-31 3.53 $-2.26 0.00
2021-12-31 3.87 $-2.27 0.00
2021-09-30 6.21 $-4.21 0.00
2021-06-30 11.78 $-5.32 0.00
2021-03-31 15.82 $-4.98 0.00
2020-12-31 6.53 $-4.76 0.00
2020-09-30 8.25 $-2.25 0.00
2020-06-30 1.50 $-0.70 0.00
2020-03-31 1.05 $-0.50 0.00
2019-12-31 0.60 $-0.35 0.00
2019-09-30 0.85 $-0.30 0.00
2019-06-30 0.55 $-0.25 0.00
2019-03-31 0.75 $-0.20 0.00
2018-12-31 0.70 $-0.05 0.00
2018-09-30 1.00 $-0.05 0.00
2018-06-30 1.10 $-0.10 0.00
2018-03-31 1.40 $0.05 28.00
2017-12-31 1.70 $-0.15 0.00
2017-09-30 2.15 $-0.15 0.00
2017-06-30 1.50 $-0.10 0.00
2017-03-31 2.50 $-0.25 0.00
2016-12-31 1.30 $-0.10 0.00
2016-09-30 1.30 $-0.10 0.00
2016-06-30 1.30 $-0.05 0.00
2016-03-31 1.50 0 0.00
2015-12-31 0.60 0 0.00
2015-09-30 0.25 0 0.00
2015-06-30 0.45 0 0.00
2015-03-31 0.90 0 0.00
2014-12-31 0.50 0 0.00
2014-09-30 0.65 0 0.00
2014-06-30 0.70 0 0.00
2014-03-31 1.25 0 0.00
2013-12-31 1.30 0 0.00
2013-09-30 1.30 0 0.00
2013-06-30 1.45 0 0.00
2013-03-31 0.65 0 0.00
2012-12-31 0.80 0 0.00
2012-09-30 0.90 0 0.00
2012-06-30 0.80 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.523B $0.212B
LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.174B 25.17
Elevance Health (ELV) United States $86.874B 11.21
CVS Health (CVS) United States $76.179B 9.47
Cencora (COR) United States $56.230B 19.56
DiDi Global (DIDIY) China $23.297B 35.36
Natera (NTRA) United States $20.821B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.571B 13.31
EUROFINS SCIENT (ERFSF) Luxembourg $12.522B 0.00
CochLear (CHEOY) Australia $11.391B 0.00
Revvity (RVTY) United States $10.665B 18.35
ICON (ICLR) Ireland $10.255B 9.53
Viatris (VTRS) United States $9.976B 3.43
Doximity (DOCS) United States $9.570B 44.57
Avantor (AVTR) United States $8.763B 12.73
HealthEquity (HQY) United States $8.657B 42.59
Medpace Holdings (MEDP) United States $8.422B 22.37
Sonic Healthcare (SKHHY) Australia $8.157B 0.00
Charles River Laboratories (CRL) United States $6.660B 13.05
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $3.994B 36.97
Bausch + Lomb (BLCO) Canada $3.976B 23.44
Sotera Health (SHC) United States $3.480B 19.77
Surgery Partners (SGRY) United States $2.896B 37.67
Alignment Healthcare (ALHC) United States $2.867B 0.00
Concentras Parent (CON) United States $2.744B 15.86
Organon (OGN) United States $2.259B 2.40
Ardent Health Partners (ARDT) United States $2.117B 9.02
GeneDx Holdings (WGS) United States $1.921B 73.99
Premier (PINC) United States $1.910B 14.50
Progyny (PGNY) United States $1.791B 39.42
PACS (PACS) United States $1.494B 0.00
GoodRx Holdings (GDRX) United States $1.364B 27.29
Teladoc Health (TDOC) United States $1.211B 0.00
Pediatrix Medical (MD) United States $1.200B 9.13
Establishment Labs Holdings (ESTA) $1.066B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.953B 14.88
Agilon Health (AGL) United States $0.911B 0.00
Nutex Health (NUTX) United States $0.901B 13.61
AMN Healthcare Services Inc (AMN) United States $0.830B 7.77
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.614B 4.14
InnovAge Holding (INNV) United States $0.543B 0.00
Enhabit (EHAB) United States $0.520B 42.75
Auna S.A (AUNA) Luxembourg $0.505B 11.37
Sonida Senior Living (SNDA) United States $0.465B 0.00
SBC Medicals (SBC) United States $0.398B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.388B 0.00
Oncology Institute (TOI) United States $0.226B 0.00
Beauty Health (SKIN) United States $0.217B 0.00
Performant Healthcare (PHLT) United States $0.214B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.137B 22.33
OncoCyte (OCX) United States $0.098B 0.00
So-Young (SY) China $0.088B 0.00
Sera Prognostics (SERA) United States $0.071B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.052B 0.00
Pheton Holdings (PTHL) China $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Basel Medical Group (BMGL) Singapore $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00